612 related articles for article (PubMed ID: 24170744)
1. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles.
Blackwell LF; Vigil P; Cooke DG; d'Arcangues C; Brown JB
Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744
[TBL] [Abstract][Full Text] [Related]
2. Monitoring of ovarian activity by measurement of urinary excretion rates using the Ovarian Monitor, Part IV: the relationship of the pregnanediol glucuronide threshold to basal body temperature and cervical mucus as markers for the beginning of the post-ovulatory infertile period.
Blackwell LF; Vigil P; Alliende ME; Brown S; Festin M; Cooke DG
Hum Reprod; 2016 Feb; 31(2):445-53. PubMed ID: 26677961
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of ovarian activity by measurement of urinary excretion rates of estrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part II: reliability of home testing.
Blackwell LF; Vigil P; Gross B; d'Arcangues C; Cooke DG; Brown JB
Hum Reprod; 2012 Feb; 27(2):550-7. PubMed ID: 22131389
[TBL] [Abstract][Full Text] [Related]
4. Mean versus individual hormonal profiles in the menstrual cycle.
Alliende ME
Fertil Steril; 2002 Jul; 78(1):90-5. PubMed ID: 12095496
[TBL] [Abstract][Full Text] [Related]
5. Correlation of ovarian follicle size and the urinary excretion of oestrone glucuronide, luteinizing hormone and pregnanediol glucuronide in spontaneous cycles.
Adekunle AO; Collins WP; Whitehead MI
Afr J Med Med Sci; 1988 Jun; 17(2):77-82. PubMed ID: 2843021
[TBL] [Abstract][Full Text] [Related]
6. The prediction and/or detection of ovulation by means of urinary steroid assays.
Cekan SZ; Beksac MS; Wang E; Shi S; Masironi B; Landgren BM; Diczfalusy E
Contraception; 1986 Apr; 33(4):327-45. PubMed ID: 3731775
[TBL] [Abstract][Full Text] [Related]
7. Monitoring the menstrual cycle: Comparison of urinary and serum reproductive hormones referenced to true ovulation.
Roos J; Johnson S; Weddell S; Godehardt E; Schiffner J; Freundl G; Gnoth C
Eur J Contracept Reprod Health Care; 2015; 20(6):438-50. PubMed ID: 26018113
[TBL] [Abstract][Full Text] [Related]
8. Postpartum return of ovarian activity in nonbreastfeeding women monitored by urinary assays.
Gray RH; Campbell OM; Zacur HA; Labbok MH; MacRae SL
J Clin Endocrinol Metab; 1987 Apr; 64(4):645-50. PubMed ID: 3818896
[TBL] [Abstract][Full Text] [Related]
9. The concentrations of urinary oestrone-3-glucuronide, LH and pregnanediol-3alpha-glucuronide as indices of ovarian function.
Collins WP; Collins PO; Kilpatrick MJ; Manning PA; Pike JM; Tyler JP
Acta Endocrinol (Copenh); 1979 Feb; 90(2):336-48. PubMed ID: 419920
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of ovulation by low-dose mifepristone (RU 486).
Ledger WL; Sweeting VM; Hillier H; Baird DT
Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
[TBL] [Abstract][Full Text] [Related]
11. Monitoring the menstrual cycle of humans and lowland gorillas based on urinary profiles of bioactive follicle-stimulating hormone and steroid metabolites.
Dahl KD; Czekala NM; Lim P; Hsueh AJ
J Clin Endocrinol Metab; 1987 Mar; 64(3):486-93. PubMed ID: 3102537
[TBL] [Abstract][Full Text] [Related]
12. Monitoring ovarian cycle activity via progestagens in urine and feces of female mountain gorillas: A comparison of EIA and LC-MS measurements.
Habumuremyi S; Robbins MM; Fawcett KA; Deschner T
Am J Primatol; 2014 Feb; 76(2):180-91. PubMed ID: 24123105
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of using paper impregnated with urine instead of liquid urine for assessing ovarian activity.
Wasalathanthri S; Tennekoon KH; Sufi S
Ceylon Med J; 2003 Mar; 48(1):4-6. PubMed ID: 12795010
[TBL] [Abstract][Full Text] [Related]
14. Hormonal monitoring of ovarian activity using the Ovarian Monitor, part I. Validation of home and laboratory results obtained during ovulatory cycles by comparison with radioimmunoassay.
Blackwell LF; Brown JB; Vigil P; Gross B; Sufi S; d'Arcangues C
Steroids; 2003 May; 68(5):465-76. PubMed ID: 12798498
[TBL] [Abstract][Full Text] [Related]
15. The validation of the Billings ovulation method by laboratory research and field trials.
Billings JJ
Acta Eur Fertil; 1991; 22(1):9-15. PubMed ID: 1746210
[TBL] [Abstract][Full Text] [Related]
16. Definition of the potentially fertile period from urinary steroid excretion rates. Part II. A threshold value for pregnanediol glucuronide as a marker for the end of the potentially fertile period in the human menstrual cycle.
Blackwell LF; Brown JB; Cooke D
Steroids; 1998 Jan; 63(1):5-13. PubMed ID: 9437789
[TBL] [Abstract][Full Text] [Related]
17. Personal hormone monitoring for contraception.
Bonnar J; Flynn A; Freundl G; Kirkman R; Royston R; Snowden R
Br J Fam Plann; 1999 Jan; 24(4):128-34. PubMed ID: 10023097
[TBL] [Abstract][Full Text] [Related]
18. Measurement of estrone-3-glucuronide and pregnanediol-3 alpha-glucuronide in early morning urine samples to monitor ovarian function.
Magini A; Pinzani P; Bolelli GF; Bassi F; Salerno R; Messeri G; Pazzagli M
J Biolumin Chemilumin; 1989 Jul; 4(1):567-74. PubMed ID: 2801241
[TBL] [Abstract][Full Text] [Related]
19. Determination of the time of ovulation in chimpanzees by measurement of LH, estrone sulfate, and pregnanediol 3 alpha-glucuronide in urine: comparison with serum hormone patterns.
Steinetz BG; Ducrot C; Randolph C; Mahoney CJ
J Med Primatol; 1992 Jul; 21(5):239-45. PubMed ID: 1404332
[TBL] [Abstract][Full Text] [Related]
20. Use of the Home Ovarian Monitor in pregnancy avoidance.
Brown JB; Holmes J; Barker G
Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):2008-11. PubMed ID: 1755460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
